Radiothermotherapy for glioblastoma multiforme: A preliminary study

Authors

  • Leila Khalafi Department of medical physics school of medicine Iran university of medical sciences, Tehran, Iran
  • Seied Rabie Mahdavi Department of medical physics school of medicine Iran university of medical sciences, Tehran, Iran
Abstract:

Introduction: Glioblastoma multiforme (GBM) is a highly radioresistant cancer with low survival rate. Current therapy approaches have failed to treat GBM. The aim of this study was to assess how GBM tumors respond to combination of hyperthermia and radiotherapy. Materials and Methods:   In this study, 38 GBM patients were included. 19 patients were treated with 60 Gy radiations in 30 fractions and 19 patients received 60 Gy radiation and 10-12 hyperthermia seasons. Hyperthermia was done using 13.56 MHz radiofrequency radiation, with capacity electrodes. All hyperthermia regimens were delivered one hour before radiotherapy. For all patients, Karnofsky Performance Status (KPS) and tumor volumes were assessed before and 3 months after treatment. Results: Our results showed that KPS was improved in hyperthermia group rather than radiotherapy group. In regard to tumor volume changes, 2 and 3 patients had more than 50% and 20-50% decrease in tumor volume post radiotherapy respectively and 7 patients had no change. Also, 2 and 5 radiotherapy patients had more than 50% and 20-50% increase in tumor volume respectively. In hyperthermia groups 8 and 4 patients had more than 50% and 20-50% decrease in tumor volume respectively and 5 patients had no changes. In addition, 2 patients had 20-50% increase in tumor volume. Conclusion: Our results identified that combination of hyperthermia and radiation is a feasible approach to treat GBM patients and patients quality of life.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Glioblastoma Multiforme: A Single Hospital Experience

Background & Aim: Glioblastoma multiforme (GBM), the highest grade glioma (grade IV), is the most malignant form of astrocytoma in adults. This study aimed at evaluating the relationship between demographic, clinical and medical factors with GBM outcome. Methods & Materials/Patients: Through a cross-sectional design, 58 patients with newly diagnosed GBM were studied from 1999 to 2015 in Guil...

full text

Glioblastoma Multiforme in Children, A Case-Report

ABSTRACT: Glioblastoma multiforme is the most malignant primary brain tumor .It usually occurs in the 5th and 6th decades of life and is rare in childern. In this paper a case of glioblastoma multiforme is reported in a ten year - old child who presented with two week's history of headache with no neurological defect.C.T scan revealed å right frontal mass with massive surrounding oedema. He w...

full text

Glioblastoma Multiforme

1 Penn State Institute of the Neurosciences and Penn State Cancer Institute, Hershey, PA 17033, USA 2The Ohio State University College of Medicine, Columbus, OH 43210, USA 3Departments of Health Evaluation Sciences and Neurosurgery, Penn State College of Medicine/Penn State Milton S. Hershey Medical Center, Hershey, PA 17033, USA 4Radiation Oncology Brain Tumor Laboratory, University of Alabama...

full text

In Vitro Effects of Selenium on Human Glioblastoma Multiforme Cell Lines: A Preliminary Study

Glioblastoma multiforme (GBM) is caused by the central nervous system-derived glial cells, and represents the most common (50%-60%) form of primary brain tumors. The aim of this study was to investigate the in vitro effects of selenium on human GBM cells. In the present study, GMS-10 and DBTRG-05MG human GBM cell lines were used as a model to examine selenium entering the cell, cell proliferati...

full text

glioblastoma multiforme: a single hospital experience

background & aim: glioblastoma multiforme (gbm), the highest grade glioma (grade iv), is the most malignant form of astrocytoma in adults. this study aimed at evaluating the relationship between demographic, clinical and medical factors with gbm outcome. methods & materials/patients: through a cross-sectional design, 58 patients with newly diagnosed gbm were studied from 1999 to 2015 in guilan ...

full text

Designer therapies for glioblastoma multiforme.

Primary brain tumors account for less than 2% of all cancers in adults; however, they are often associated with neurologic morbidity and high mortality. Glioblastoma multiforme (GBM) has been a focus of new therapy development in neurooncology because it is the most common primary brain tumor in adults. Standard-of-care therapy for newly diagnosed GBM includes surgical resection, radiotherapy, ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 15  issue Special Issue-12th. Iranian Congress of Medical Physics

pages  89- 89

publication date 2018-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023